20. October 2026
MonTa Bioscience is currently testing its cancer treatment in melanoma patients
MonTa Bioscience, a spin-out from DTU, is developing new cancer treatments designed to activate the body’s immune system. The company’s treatment originated as a research project at DTU. In 2019, MonTa Bioscience moved to DTU...